Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-08

Clinical Trial Update: Treatment of Sebaceous Hyperplasia With PDL and Nd:YAG Versus Erbium:YAG: A Randomized Controlled Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing Pulsed Dye Laser with Nd:YAG versus Erbium:YAG lasers for treating sebaceous hyperplasia; currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erbium-doped YAG laser (Erbium:YAG laser) (erbium-doped yttrium aluminum garnet laser)
  • Neodymium-doped YAG laser (Nd:YAG laser) (neodymium-doped yttrium aluminum garnet laser)
  • Pulsed Dye Laser (PDL) (pulsed dye laser)

Snippet

Sponsor: Northwestern University | Conditions: Sebaceous Hyperplasia | Phase 2 | Status: NOT_YET_RECRUITING